AnalysisNews

RGNT today

$0.84-$0.30 (-26.34%)close Nov 19, 2026

Trend

DailyDowntrend (confirmed)

4 hourStrong Bearish

1 hourSymmetric Triangle

15 minStrong Bearish

5 minStrong Bearish

Daily trend turns up above $1.47

Key levels

Resistance$1.47

Resistance$1.16

Latest news & SEC filings

DealRegentis Biomaterials signs exclusive distribution deal for GelrinC in Israel

DealRegentis Biomaterials to sell GelrinC in Israel via AMI Medical Technologies partnership

All RGNT news →

About Regentis Biomaterials

Regentis Biomaterials is a regenerative medicine company that develops hydrogel implants for repairing orthopedic tissue. Its main product, GelrinC, is a ready-made implant placed in the knee to treat damage to articular cartilage, and it is cleared for sale in Europe. The company is conducting a clinical study across the United States, Europe and Israel to support approval in the U.S. It is based in Herzliya, Israel.

Based on the company's 20-F filed Feb 24, 2026.

NYSE · Healthcare

REGENTIS BIOMATERIALS LTD. (RGNT)

$0.84-0.30 (-26.34%)
HOLDGrade: DRisk: MEDIUM
1D5D1M1Y5YMaxSign up for all timeframes
1.001.161.311.470.84Oct 19Oct 27Nov 4Nov 12
High1.08
Low0.81
Open0.84
Volume167K
Avg Vol40K
VWAP0.93
30d High1.63
30d Low0.84
30d Chg-47.52%

What Is the Price Target for RGNT?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $1.14Upside: +0.0%Confidence: 20%Method: No Coverage

Is RGNT a Buy or Sell Right Now?

32
Investability Score
HOLD12-18 months

Test your own strategy on RGNT

Describe your strategy in plain words, then scan, alert, backtest and paper trade it on RGNT with SEPT’s own market data.

Start Free Trial →

Is RGNT Overvalued or Undervalued?

Valuation Verdict

N/A

Methods Used

N/A

Fair Value

$N/A

7

Moat Score

NONE

3/9

Piotroski Score

-13.1

Altman Z-Score

What Is Smart Money Doing with RGNT?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

LOW

Signal: NEUTRAL

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See Smart Money Data →

RGNT Growth Story

Revenue YoY

N/A%

3yr Revenue CAGR

N/A%

EPS Growth YoY

-1504.65%

FCF Growth YoY

N/A%

Revenue Trend

UNKNOWN

Dark Pool Trades for RGNT

PREVIEW

Recent off-exchange (dark pool) prints for RGNT: size, dollar value and side. One of the data views on SEPT, alongside its own pressure bars, swings, volume spike levels and key levels.

TimePriceSizeValueSide
20:57:16$0.841,000$$840BUY
20:50:58$0.851,000$$846BUY
20:43:58$0.901,050$$945BUY
19:52:10$1.011,570$$2KBUY
19:46:30$1.011,000$$1KBUY

5 dark pool trades shown · $$5K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for REGENTIS BIOMATERIALS LTD. (RGNT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

Your strategy, tested before real money.

Describe your strategy in plain words. SEPT scans, alerts, backtests and paper trades it on its own market data. SEPT provides tools only and does not tell you what to buy or sell.

Try SEPT Free for 7 Days →

RGNT — frequently asked questions

What is RGNT stock price today?

REGENTIS BIOMATERIALS LTD. (RGNT) is at $0.84, down 26.34% (-$0.30) at the Nov 19, 2026 close.

Why is RGNT stock moving today?

Latest RGNT news — Nov 11, 2026: Regentis Biomaterials signs exclusive distribution deal for GelrinC in Israel · Nov 9, 2026: Regentis Biomaterials to sell GelrinC in Israel via AMI Medical Technologies partnership

What are RGNT support and resistance levels?

Resistance: $1.16, $1.47, $1.69.

What are insiders doing with RGNT?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

What is the latest news on RGNT?

Nov 11, 2026: Regentis Biomaterials signs exclusive distribution deal for GelrinC in Israel · Nov 9, 2026: Regentis Biomaterials to sell GelrinC in Israel via AMI Medical Technologies partnership